SMALL AIRWAY FUNCTION IMPROVEMENT WITH MEPOLIZUMAB IN SEVERE EOSINOPHILIC ASTHMA

被引：0
|
作者：
Farah, C. [1 ,2 ,3 ,4 ]
Seccombe, L. [1 ,2 ]
Rogers, P. [1 ]
Reed, N. [1 ]
Badal, T. [1 ,3 ]
Thamrin, C. [2 ,3 ]
King, G. [2 ,3 ,5 ]
Peters, M. [1 ,2 ,4 ]
机构：
[1] Concord Hosp, Dept Thorac Med, Concord, Australia
[2] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia
[3] Woolcock Inst Med Res, Glebe, NSW, Australia
[4] Macquarie Univ, Fac Med & Hlth Sci, N Ryde, NSW, Australia
[5] Royal North Shore Hosp, Dept Resp Med, St Leonards, NSW, Australia
来源：
RESPIROLOGY | 2018年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
TP 204
引用
收藏
页码：213 / 213
页数：1
相关论文
共 50 条
  • [21] Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
    Ortega, Hector G.
    Liu, Mark C.
    Pavord, Ian D.
    Brusselle, Guy G.
    FitzGerald, J. Mark
    Chetta, Alfredo
    Humbert, Marc
    Katz, Lynn E.
    Keene, Oliver N.
    Yancey, Steven W.
    Chanez, Pascal
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (13): : 1198 - 1207
  • [22] OUTCOMES WITH MEPOLIZUMAB AND BENRALIZUMAB IN SEVERE EOSINOPHILIC ASTHMA
    Elsey, L.
    Hince, K.
    Aspin, P.
    Pantin, C. T.
    Allen, D.
    Niven, R.
    Fowler, S. J.
    Tavernier, G.
    THORAX, 2021, 76 : A142 - A142
  • [23] Mepolizumab for the reduction of exacerbations in severe eosinophilic asthma
    Russell, Richard
    Brightling, Christopher
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2016, 10 (06) : 607 - 617
  • [24] Asthma Control In Patients With Severe Eosinophilic Asthma Treated With Mepolizumab
    Llanos-Ackert, J. -P.
    Price, R. G.
    Forshag, M.
    Yancey, S.
    Liu, M. C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [25] Mepolizumab improves activity limitation in severe eosinophilic asthma
    Albers, Frank
    Nelsen, Linda M.
    Bratton, Daniel J.
    Bradford, Eric S.
    Braunstahl, G. J.
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [26] Oscillometry in severe eosinophilic asthma commencing mepolizumab or benralizumab
    Fernando, M.
    Jeffrey, B.
    Tierney, C.
    Seccombe, L.
    Peters, M.
    Farah, C.
    Cottee, A.
    RESPIROLOGY, 2023, 28 : 81 - 81
  • [27] CLINICAL RESPONSE TO MEPOLIZUMAB IN PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA
    Harvey, E.
    Langton, D.
    Powell, H.
    Gibson, P.
    RESPIROLOGY, 2019, 24 : 42 - 42
  • [28] Effect of mepolizumab in airway remodeling in patients with late-onset severe asthma with an eosinophilic phenotype
    Domvri, Kalliopi
    Tsiouprou, Ioanna
    Bakakos, Petros
    Steiropoulos, Paschalis
    Katsoulis, Konstantinos
    Kostikas, Konstantinos
    Antoniou, Katerina M.
    Papaioannou, Andriana I.
    Rovina, Nikoletta
    Katsaounou, Paraskevi
    Papamitsou, Theodora
    Pastelli, Nicoleta
    Tryfon, Stavros
    Fouka, Evangelia
    Papakosta, Despoina
    Loukides, Stelios
    Porpodis, Konstantinos
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2025, 155 (02) : 425 - 435
  • [29] Secondary loss of response to mepolizumab in severe eosinophilic asthma
    Cormier, Maxime
    Chaboillez, Simone
    Lemiere, Catherine
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (02): : 736 - 738
  • [30] Airway autoimmune responses in severe eosinophilic asthma following low-dose Mepolizumab therapy
    Manali Mukherjee
    Hui Fang Lim
    Sruthi Thomas
    Douglas Miller
    Melanie Kjarsgaard
    Bruce Tan
    Roma Sehmi
    Nader Khalidi
    Parameswaran Nair
    Allergy, Asthma & Clinical Immunology, 13
12345